-$5.51 (-2.17%)
| Source | Headline |
|---|---|
|
Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is up 24.03% year to date and 65.92% over the past year, riding oncology strength and a raised full-year outlook. 247wallst.com - 2026-07-15 13:29:04 |
|
Wall Street Lunch: Dan Ives Teams Up With Yorkville Securities To Launch Merchant Bank
Tech analyst Dan Ives announced that he has teamed up with Yorkville Securities to form a new kind of merchant bank. Johnson & Johnson (JNJ) beat Q2 estimates and raised guidance, but EPS decline weighed on sentiment despite innovative medicine strength. seekingalpha.com - 2026-07-15 12:32:00 |
|
Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Pfizer (NYSE:PFE) both closed Q1 2026 with earnings beats, yet their post-report stories look nothing alike. 247wallst.com - 2026-07-15 12:27:23 |
|
J&J Leverages AI and Robots to Target $100 Billion in Annual Revenue
The launch of artificial intelligence-powered imaging and mapping capabilities for electrophysiology, early momentum for a drug releasing system for bladder cancer treatment, and progress toward a table-integrated robotic surgical system are among the latest innovations from pharmaceuticals and MedTech company Johnson & Johnson. pymnts.com - 2026-07-15 12:09:07 |
|
Producer Inflation Cools in June
Pre-market futures are gathering steam following this morning's slew of economic data, which was quite encouraging overall. Wholesale inflation and another round of Q2 earnings results, along with a New York manufacturing index, has seen the blue-chip Dow up from +99 points to +140 at this hour. zacks.com - 2026-07-15 11:55:34 |
|
J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised
JNJ tops Q2 earnings and sales estimates, driven by key drug growth, and raises its 2026 outlook despite a slight MedTech sales miss. zacks.com - 2026-07-15 11:51:04 |
|
Johnson & Johnson Q2: Solid (If Not Spectacular) Performance Satisfies Wall Street
Johnson & Johnson delivered strong Q2 2026 results, with 6.6% annual revenue growth and robust performance across Pharma and MedTech divisions. JNJ maintains mid-to-high single digit revenue growth, a portfolio of 15+ "blockbuster" drugs, and a solid pipeline, supporting its blue-chip status. I am downgrading JNJ from Strong Buy to Buy due to valuation normalization and tempered forward share price expectations, despite continued operational strength. seekingalpha.com - 2026-07-15 11:34:13 |
|
FTSE 100 Live: Miners drag on China slowdown, oil shrugs off new Iran strikes
FTSE 100 up 7 points at 10,537 Miners fall on weaker China GDP Barratt Redrow, ICG, B&M, NextEnergy Solar publish updates 2.50pm: US stocks open higher,... proactiveinvestors.com - 2026-07-15 10:51:00 |
|
Johnson & Johnson beats Q2 estimates, raises full-year 2026 guidance
Johnson & Johnson (NYSE:JNJ) reported better-than-expected second quarter results and raised its full-year 2026 outlook, as strong pharmaceutical sales helped offset headwinds from products facing patent competition. The healthcare company posted adjusted earnings per share of $2.90 for the quarter, ahead of the Wall Street consensus estimate of $2.85. proactiveinvestors.com - 2026-07-15 10:44:58 |
|
JNJ Struggles for Direction Despite Notable Q2 Beat
Johnson & Johnson (NYSE:JNJ) is up 0.5% at $255.03 this morning, attempting to pivot higher and shed its early pre-market losses. schaeffersresearch.com - 2026-07-15 10:39:21 |
|
Johnson & Johnson (JNJ) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 2026-07-15 10:31:05 |
|
Johnson & Johnson Q2 Earnings Call Highlights
Johnson & Johnson NYSE: JNJ raised its full-year 2026 outlook after reporting second-quarter sales growth that management said was supported by strength in Innovative Medicine, new product launches and a broad portfolio that helped offset continued pressure from STELARA biosimilar competition. marketbeat.com - 2026-07-15 10:05:37 |
|
Walmart vs Johnson & Johnson: Two Defensive Plays, Diverging Strategies and One Winner
Walmart (NYSE:WMT | WMT Price Prediction) and Johnson & Johnson (NYSE:JNJ) just delivered results that show two defensive giants pulling on very different levers. 247wallst.com - 2026-07-15 10:00:27 |
|
Chips Lead Nasdaq Futures Higher Amid Middle East Tensions
Stocks are moving higher the Nasdaq 100-Index (NDX) and Dow Jones Industrial Average (DJI) surging triple digits schaeffersresearch.com - 2026-07-15 09:17:00 |
|
5 Things to Know Before the Stock Market Opens on Wednesday
Stock futures are pointing to a higher open as investors digest a flurry of earnings reports from major companies; oil prices are higher as the U.S. and Iran continue to trade strikes; PayPal shares are surging following a report that Stripe and Advent International have made a joint offer to buy the payments giant; ASML shares are gaining after the maker of chip manufacturing equipment reported strong results and lifted its sales forecast; and Morgan Stanley, Johnson & Johnson, Conagra and United are among the other big names reporting earnings today. Here's what you need to know today. investopedia.com - 2026-07-15 09:01:00 |
|
Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.9 per share, beating the Zacks Consensus Estimate of $2.84 per share. This compares to earnings of $2.77 per share a year ago. zacks.com - 2026-07-15 08:30:11 |
|
FTSE 100 Live: Miners drag on China slowdown, PayPal jumps on bid
FTSE 100 down 23 points to 10,506 Miners fall on weaker China GDP Barratt Redrow, ICG, B&M, NextEnergy Solar publish updates 12.13pm: European stocks in... proactiveinvestors.com - 2026-07-15 08:13:00 |
|
Nasdaq continues rally as PayPal climbs on bid, BlackRock earnings impress
12:05pm: More impressive bank earnings Morgan Stanley (NYSE:MS) (Morgan Stanley (NYSE:MS)) reported record second quarter revenue and profit that topped... proactiveinvestors.com - 2026-07-15 08:09:00 |
|
The State Tax Trap: Where the Same Retirement Portfolio Buys You Thousands More Every Year
Picture two retirees with identical $1.5 million portfolios throwing off $80,000 a year in taxable portfolio income. One lives in Naples, Florida. The other lives in San Diego. If that income is taxed as ordinary income and falls in California's 9.3% bracket, the California retiree could lose about $7,440 a year to state income tax... The State Tax Trap: Where the Same Retirement Portfolio Buys You Thousands More Every Year 247wallst.com - 2026-07-15 08:02:25 |
|
ASML, Intel, Johnson & Johnson, and More Stocks That Explain Today's Market
Stocks look set to build on their recent gains as investors try to make sense of another batch of quarterly earnings reports. barrons.com - 2026-07-15 07:27:00 |
|
Johnson & Johnson Hikes Guidance, Stock Falls
The drugmaker posts earnings that narrowly beat expectations and raises its full-year outlook. barrons.com - 2026-07-15 06:35:00 |
|
Johnson & Johnson Bumps Up Guidance as Sales Rise
The drug and medical-device maker raised its forecast for the year after recording higher sales in the second quarter. wsj.com - 2026-07-15 06:33:00 |
|
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2026 of $1.34 per share on the company's common stock. The dividend is payable on September 8, 2026 to shareholders of record at the close of business on August 25, 2026. The ex-dividend date is August 25, 2026. About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare inn. businesswire.com - 2026-07-15 06:25:00 |
|
J&J quarterly earnings beat Wall Street estimates on strength of medicines unit
Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as strong growth from immunology drug Tremfya and cancer blockbuster Darzalex more than offset erosion from older products and a drop in sales for heart pumps it picked up in its 2022 acquisition of Abiomed. reuters.com - 2026-07-15 06:23:09 |
|
Johnson & Johnson reports Q2 2026 results, raises 2026 outlook
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2026. “Johnson & Johnson delivered strong second-quarter results, demonstrating the power of our innovation, the depth of our portfolio and the momentum in our pipeline as we advance transformative treatments that address the world's toughest health challenges,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “With raised guidance and quarterly. businesswire.com - 2026-07-15 06:20:00 |
|
What It Takes to Earn $8,000 a Month From Dividends Without Chasing Yield
Eight thousand dollars a month is the kind of retirement income target that looks simple until the yield math starts moving underneath it. It translates to $96,000 a year, but the portfolio needed to produce that income can vary by well over $1 million depending on whether the investor accepts a 3.5% yield, a 6%... What It Takes to Earn $8,000 a Month From Dividends Without Chasing Yield 247wallst.com - 2026-07-15 06:17:09 |
|
Nasdaq continues rally at open as PayPal climbs on bid, BlackRock earnings impress
10am: PayPal and BlackRock lead Wall St higher at open Wall Street has opened Wednesday trading on the front foot, with investors digesting more earnings.... proactiveinvestors.com - 2026-07-15 06:00:00 |
|
Morgan Stanley, Johnson & Johnson And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: benzinga.com - 2026-07-15 02:29:24 |
|
This Healthcare Giant Still Checks Every Box for Long-Term Investors
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) has been one of 2026's quieter winners in large-cap healthcare, and our proprietary model sees room to run. 247wallst.com - 2026-07-14 12:30:20 |
|
Wall Street closes higher as cooling inflation lifts chip stocks, rate hopes
4:20pm: Rate hopes lift markets US stocks finished mostly higher on Tuesday after a softer-than-expected inflation report boosted hopes that the Federal... proactiveinvestors.com - 2026-07-14 12:25:00 |
|
A $1.4 Million Portfolio That Delivers Reliable Income Through Bull and Bear Markets
A $1.4 million nest egg is far above the typical U.S. retirement account balance, but the check it writes each month depends entirely on how the assets are arranged. At a 3.5% yield, the portfolio produces $49,000 a year. At a 10% yield, it produces $140,000. The difference looks simple on a spreadsheet, but it... A $1.4 Million Portfolio That Delivers Reliable Income Through Bull and Bear Markets 247wallst.com - 2026-07-14 12:12:27 |
|
Johnson & Johnson Q2 Preview: Stock Near All-Time Highs, Market Expert Sees Rally to $282 – ‘Continue Their Winning Ways'
Health care giant Johnson & Johnson (NYSE:JNJ) reports second-quarter financial results on Wednesday before the market opens. Here are the earnings estimates, what experts are saying and key items to watch. benzinga.com - 2026-07-14 11:55:20 |
|
Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge
JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure. zacks.com - 2026-07-14 10:56:28 |
|
A Dividend Portfolio That Can Cover the Cost of Living in San Francisco
San Francisco makes passive income math unforgiving. SmartAsset's 2026 comfort-salary study estimates that a single adult needs about $134,950 in pretax income to live comfortably in the city, among the highest figures in the country. Turning that paycheck into dividend income is not just a yield exercise. The yield an investor reaches for changes both... A Dividend Portfolio That Can Cover the Cost of Living in San Francisco 247wallst.com - 2026-07-14 10:03:33 |
|
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
Johnson & Johnson (NYSE:JNJ) will release its second-quarter earnings report before the opening bell on Wednesday, July 15. benzinga.com - 2026-07-14 08:40:20 |
|
CleanSpark shares surge after company secures $6.6B data center lease agreement
CleanSpark Inc (NASDAQ:CLSK) shares surged more than 12% after the company announced a 20-year lease agreement for its Sandersville, Georgia data center... proactiveinvestors.com - 2026-07-14 07:53:00 |
|
|
Tower Semiconductor shares jump as company announces Japan expansion to boost silicon photonics capacity
Tower Semiconductor (NASDAQ:TSEM) shares rose 13% on Tuesday after the company announced a strategic expansion of its silicon photonics, silicon germanium... proactiveinvestors.com - 2026-07-14 07:20:00 |
|
This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy?
The dividend looks secure. The share price is the harder call. fool.com - 2026-07-14 03:41:00 |
|
Is Johnson & Johnson Stock Poised for New Highs as Q2 Results Approach?
After hitting fresh all-time highs last week, investors are turning their attention to JNJ's Q2 report, which is scheduled for Wednesday, July 15, before the opening bell. zacks.com - 2026-07-13 18:51:20 |
|
How Much of Your Social Security Will You Actually Keep After Taxes?
Social Security benefits come with inflation protection, but the tax formula attached to those benefits does not. For retirees with pensions, IRA withdrawals, taxable investment income, or municipal bond interest, a larger benefit can quietly mean a larger federal tax bill. The result is a tax rule from the 1980s that reaches more retirees every... How Much of Your Social Security Will You Actually Keep After Taxes? 247wallst.com - 2026-07-13 14:28:09 |
|
How To Build A $50,000 Dividend Portfolio In Today's Market
The Dividend Income Accelerator Portfolio emphasizes high-quality companies with sustainable dividends, strong balance sheets, and attractive valuations to optimize risk-adjusted returns. I prioritize a diversified mix of ETFs and individual stocks across sectors, balancing dividend income, growth, and capital appreciation while mitigating downside risk. Key metrics include a 3.75% weighted average dividend yield, low payout ratios, and low beta factors, supporting long-term portfolio resilience. seekingalpha.com - 2026-07-13 13:45:49 |
|
Stock Indexes Split as Chip Stocks Fall, Oil Surges
Why are chip stocks collapsing while the Dow barely budges? Korean markets just had their worst day since the 2008 financial crisis, and the fallout is hitting semiconductors hard. fool.com - 2026-07-13 12:23:17 |
|
JNJ Vs. KO: Which Dividend Stock Is The Better Buy?
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Coca-Cola (NYSE:KO) both delivered Q1 2026 beats and both are being crowded into by capital rotating out of tech. 247wallst.com - 2026-07-13 12:22:59 |
|
Is JNJ Stock a Buy, Sell or Hold Ahead of Q2 Earnings Release?
JNJ is set to report second-quarter results on July 15 as investors weigh strong growth drivers, new launches and patent headwinds shaping its long-term outlook. zacks.com - 2026-07-13 11:45:20 |
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. zacks.com - 2026-07-13 09:56:19 |
|
The Real Case for Buying Johnson & Johnson (JNJ) Before July 15
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is the easiest healthcare name to evaluate on the board heading into its July 15 earnings release, and the setup leaves little to debate. 247wallst.com - 2026-07-13 08:30:17 |
|
This Portfolio Lets You Earn More Than a Lawyer... Without Going to Law School
A legal career can eventually deliver a six-figure income, but the path is rarely passive. The median annual wage for lawyers was $151,160 in May 2024, and attorneys in higher-paid roles can clear $200,000 or more. The tradeoff is years of training, tuition, billable hours, and pressure that does not disappear when the workday ends.... This Portfolio Lets You Earn More Than a Lawyer... Without Going to Law School 247wallst.com - 2026-07-13 06:45:04 |
|
The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000
The math on replacing $60,000 of annual income looks simple until you ask a different question. At a 3.5% yield, you need roughly $1.7 million. At 6%, you need about $1 million. At 12%, you need around $500,000. Three tiers, three price tags, and three very different risk profiles. The trap is treating that choice... The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000 247wallst.com - 2026-07-13 05:00:37 |
|
3 Dividend Stocks Leading 2026's Rotation Into Value
As investors flee this year's high flyers, a few dependable payers are catching the money. fool.com - 2026-07-12 20:38:00 |
|
Billionaire Ken Griffin Boosted His Stake in This Dividend King by 146%. Here's Why It's a Dream Stock for Risk-Averse Investors.
Griffin is at the helm of the world's most profitable hedge fund. fool.com - 2026-07-12 17:10:00 |